BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34388057)

  • 1. Endothelial dysfunction and vascular complications after allogeneic hematopoietic cell transplantation: an expert analysis.
    Eftychidis I; Sakellari I; Anagnostopoulos A; Gavriilaki E
    Expert Rev Hematol; 2021 Sep; 14(9):831-840. PubMed ID: 34388057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?
    Lia G; Giaccone L; Leone S; Bruno B
    Front Immunol; 2021; 12():641427. PubMed ID: 34093530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.
    Elsallabi O; Bhatt VR; Dhakal P; Foster KW; Tendulkar KK
    Clin Appl Thromb Hemost; 2016 Jan; 22(1):12-20. PubMed ID: 26239316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation.
    Qi J; Wang J; Chen J; Su J; Tang Y; Wu X; Ma X; Chen F; Ruan C; Zheng XL; Wu D; Han Y
    Ann Hematol; 2017 Nov; 96(11):1849-1855. PubMed ID: 28801815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
    Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
    Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy.
    Dandoy CE; Tsong WH; Sarikonda K; McGarvey N; Perales MA
    Transplant Cell Ther; 2023 Apr; 29(4):282.e1-282.e9. PubMed ID: 36592719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation.
    Hildebrandt GC; Chao N
    Br J Haematol; 2020 Aug; 190(4):508-519. PubMed ID: 32319084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment of Veno-occlusive Disease, Transplantation-Associated Thrombotic Microangiopathy, and Acute Graft-vs-Host Disease in a Patient with Relapsed Epstein-Barr Hemophagocytic Lymphohistiocytosis After Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report.
    Zhang C; Tan X; Yao H; Liu Y; Gao L; Gao L; Kong PY; Zhang X
    Transplant Proc; 2019 Nov; 51(9):3159-3162. PubMed ID: 31711585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Recombinant Thrombomodulin for the Prophylaxis of Veno-Occlusive Complication in Allogeneiccit Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Kashyap R; Anwer F; Iqbal MA; Khalid F; Khan A; Ali MA; Anwar MY; Chaudhary A; Jaan A
    Hematol Oncol Stem Cell Ther; 2023 Jan; 16(2):93-101. PubMed ID: 34655527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
    Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
    Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
    Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
    Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell Transplantation.
    Gavriilaki E; Sakellari I; Anyfanti P; Batsis I; Vardi A; Bousiou Z; Lazaridis A; Nikolaidou B; Zarifis I; Masmanidou M; Yiannaki E; Markala D; Anagnostopoulos A; Douma S; Gkaliagkousi E
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in critical care of the pediatric hematopoietic stem cell transplant patient.
    Chima RS; Abulebda K; Jodele S
    Pediatr Clin North Am; 2013 Jun; 60(3):689-707. PubMed ID: 23639663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease.
    Gavriilaki E; Sakellari I; Karafoulidou I; Pasteli N; Batsis I; Mallouri D; Lazaridou A; Iskas M; Vardi A; Papalexandri A; Tsompanakou A; Papaemmanouil S; Ilias A; Anagnostopoulos A
    Int J Hematol; 2019 Nov; 110(5):529-532. PubMed ID: 31586304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
    Schoettler M; Lehmann L; Li A; Ma C; Duncan C
    Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation.
    Yamada-Fujiwara M; Miyamura K; Fujiwara T; Tohmiya Y; Endo K; Onishi Y; Ishizawa K; Kameoka J; Ito M; Harigae H
    Tohoku J Exp Med; 2012 May; 227(1):31-7. PubMed ID: 22531159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in Diagnosis and Treatment of Transplant-Associated Thrombotic Microangiopathy --Review].
    Geng YK; Wang T; Song ZQ; Yang JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):602-606. PubMed ID: 37096542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early vascular toxicity after pediatric allogeneic hematopoietic stem cell transplantation.
    Leimi L; Jahnukainen K; Olkinuora H; Meri S; Vettenranta K
    Bone Marrow Transplant; 2022 May; 57(5):705-711. PubMed ID: 35177827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study.
    Schoettler ML; French K; Harris A; Bryson E; Deeb L; Hudson Z; Obordo J; Chandrakasan S; Parikh S; Watkins B; Stenger E; Qayed M; Chonat S; Westbrook A; Switchenko J; Williams KM
    Am J Hematol; 2024 Mar; 99(3):370-379. PubMed ID: 38164997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD.
    Furukawa M; Wang X; Ohkawara H; Fukatsu M; Alkebsi L; Takahashi H; Harada-Shirado K; Shichishima-Nakamura A; Kimura S; Ogawa K; Ikezoe T
    Blood Adv; 2019 Jul; 3(14):2128-2143. PubMed ID: 31300420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.